TATAR, G. Et Al. 2017. Molecular Docking Study of Novel 1,2,3,4,-Tetrahydroisoquinoline Derivates as Anticancer Agents against epidermal growth factor (EGFR) receptor. 1. Uluslararası Kanser ve İyon Kanalları Kongresi , (Şanlıurfa, Turkey), 132.

TATAR, G., TASKIN TOK, T., HASSAN, Y., & MOHAMMED, A. D., (2017). Molecular Docking Study of Novel 1,2,3,4,-Tetrahydroisoquinoline Derivates as Anticancer Agents against epidermal growth factor (EGFR) receptor . 1. Uluslararası Kanser ve İyon Kanalları Kongresi (pp.132). Şanlıurfa, Turkey

TATAR, GİZEM Et Al. "Molecular Docking Study of Novel 1,2,3,4,-Tetrahydroisoquinoline Derivates as Anticancer Agents against epidermal growth factor (EGFR) receptor," 1. Uluslararası Kanser ve İyon Kanalları Kongresi, Şanlıurfa, Turkey, 2017

TATAR, GİZEM T. Et Al. "Molecular Docking Study of Novel 1,2,3,4,-Tetrahydroisoquinoline Derivates as Anticancer Agents against epidermal growth factor (EGFR) receptor." 1. Uluslararası Kanser ve İyon Kanalları Kongresi , Şanlıurfa, Turkey, pp.132, 2017

TATAR, G. Et Al. (2017) . "Molecular Docking Study of Novel 1,2,3,4,-Tetrahydroisoquinoline Derivates as Anticancer Agents against epidermal growth factor (EGFR) receptor." 1. Uluslararası Kanser ve İyon Kanalları Kongresi , Şanlıurfa, Turkey, p.132.

@conferencepaper{conferencepaper, author={GİZEM TATAR YILMAZ Et Al. }, title={Molecular Docking Study of Novel 1,2,3,4,-Tetrahydroisoquinoline Derivates as Anticancer Agents against epidermal growth factor (EGFR) receptor}, congress name={1. Uluslararası Kanser ve İyon Kanalları Kongresi}, city={Şanlıurfa}, country={Turkey}, year={2017}, pages={132} }